1) Surgeon General Urges More Americans to Carry Naloxone
The U.S. Surgeon General issued a public health advisory for the first time in more than a decade in which he urged more Americans to carry a medication that can reverse the effects of opioid overdoses. But the prohibitive cost of the two consumer-friendly forms of the medication may thwart widespread adoption.
2) New ICD-11 Criteria Will Reduce PTSD Diagnoses by 50%
Proposed changes to the upcoming 11th edition of the International Classification of Diseases (ICD-11) will reduce the proportion of individuals who meet diagnostic criteria for posttraumatic stress disorder (PTSD) by about 50%, a new study suggests.
3) White House Unveils Plan to Lower Cost of Prescription Drugs
Proposals to lower prescription drug prices have been announced by President Trump. A blueprint was released by the White House on Friday that seeks “to encourage innovation, while also promoting better price competition and addressing foreign freeloading”.
4) Antipsychotic May Fuel Urge to Gamble
An updated literature review provides more evidence of an association between gambling disorder and the second-generation atypical antipsychotic aripiprazole (Abilify).
5) Psychiatry Residents Woefully Unprepared to Deal With Opioid Epidemic
Incoming residents lack the experience and knowledge to address the opioid epidemic appropriately, and the vast majority of them want more formal training in opioid use disorder (OUD) during residency, preliminary results from the first wave of a cross-sectional survey show.
